Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Cancers
•
Endometrial Cancer
Would you offer consolidative radiation for oligometastatic uterine serous CA s/p surgery and chemotherapy with complete response?
Answer from: Radiation Oncologist at Community Practice
Usually not unless pelvis only confined disease at presentation or microscopic omental disease removed at surgery.
Comments
Radiation Oncologist at East Alabama Medical Center
Surgically pT3pN0 but on post op staging found to ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Was bone Mets bx proven?
Radiation Oncologist at East Alabama Medical Center
Unfortunately no, but PET avid and distinct lesion...
5004
5005
5008
Sign in or Register to read more
10819
Related Questions
How do you manage a FIGO stage IB dedifferentiated endometrial carcinoma that is MMR deficient and p53 wt?
What adjuvant treatment would you recommend for a patient with FIGO 2023 IIIB2 endometrioid endometrial adenocarcinoma (Grade 3, p53mut, MMR proficient), metastatic to the uterine serosa, bilateral ovaries, and anterior peritoneal reflection?
How do you classify extensive LVSI in endometrial cancer?
How would you sequence adjuvant chemo-immunotherapy (paclitaxel/carbo/pembro or paclitaxel/carbo/dostarlimab) with EBRT and vaginal cuff brachytherapy in advanced uterine cancer that meets clinical criteria for both EBRT and chemo-IO?
Given the negative results of GOG-0238 but the positive results of the RUBY trial, how do you manage isolated vaginal cuff recurrence of endometrial cancer?
How would you manage a POLE mutated, p53 abnormal IA myoinvasive carcinosarcoma of the endometrium with no LVSI?
How would you treat recurrent endometrial carcinoma with a presentation of inguinal and external iliac adenopathy?
What dose would you use to treat unresectable basal cell carcinoma of the vulva?
What do you view as the future role for the combination of durvalumab + olaparib + chemotherapy in the management of patients with advanced/recurrent endometrial cancer following the DUO-E trial results?
What is the optimal adjuvant vaginal brachytherapy schedule when a patient is getting concurrent chemotherapy?
Surgically pT3pN0 but on post op staging found to ...
Was bone Mets bx proven?
Unfortunately no, but PET avid and distinct lesion...